Gilead Sciences
GILDGilead Sciences, Inc. , is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Gilead Sciences
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 12/29/2025 | Sell | O'day, Daniel Patrick | Chairman & CEO | $124.8 | $1,248,272 |
| 12/15/2025 | Sell | Dickinson, Andrew D. | Chief Financial Officer | $122.0 | $366,000 |
| 12/15/2025 | Sell | Mercier, Johanna | Chief Commercial Officer | $122.0 | $366,000 |
| 11/28/2025 | Sell | Kramer, Kelly A. | Director | $127.1 | $356,516 |
| 11/28/2025 | Sell | O'day, Daniel Patrick | Chairman & CEO | $126.4 | $1,265,444 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)